Outcome of Multimodal Anesthesia Bern

NAActive, not recruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

June 16, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Opioid UsePain, PostoperativePostoperative ComplicationsPostoperative Nausea
Interventions
PROCEDURE

General anesthesia applying multimodal anesthesia

"In the multimodal anesthesia-group a combination of different opioid-sparing drugs are added for general anesthesia, dosages are as follows:~* Magnesium 2g IV~* Dexmedetomidine IV 0.3mcg/kg IBW bolus over 10 minutes, followed by 0.3mcg/kg IBW until 30 min. before the end of surgery or the maximal dosage of 1.4mcg/kg IBW.~* Ketamine IV 0.3mg/kg IBW bolus, followed by 0.3 mg/kg IBW or a max. Dose of 25mg/h, until 30 min. before the end of surgery.~* Lidocaine IV 1mg/kg IBW bolus, followed by 1mg/kg/h IBW until in PACU/ICU"

PROCEDURE

General anesthesia using conventional opioid-based regimen

Opioids (Fentanyl, Methadone, Hydromorphone) at the discretion of the treating anesthetist

Trial Locations (1)

3010

Department of Anaesthesiology and Pain Medicine, Inselspital, Bern University Hospital, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT06985069 - Outcome of Multimodal Anesthesia Bern | Biotech Hunter | Biotech Hunter